Zhao Jianjun suggested that there could be a way for Xue Chen to get 50% of the profit, which aroused Xue Chen's curiosity and wanted to hear what the idea was.
"It is difficult for those pharmaceutical companies to agree to your request because they believe that copying the technology belongs to them, and they have to provide factories and production lines, a large number of employees to produce, and are responsible for subsequent sales and services, etc., so it is difficult to accept that the profits are as high as
Less than 50%, and my solution is to let Huaxia Pharmaceutical Group be one of the partners and turn the bilateral cooperation into a tripartite cooperation."
Zhang Jianjun’s suggestion is to select one of the four major pharmaceutical companies that has mastered the replication technology as a partner, mainly responsible for providing technology, while Huaxia Pharmaceutical Group Corporation will provide the factory buildings, equipment and personnel. This part is the most expensive and the most expensive.
On the one hand, capital is needed. Finally, Xue Chen comes to provide the raw materials for the magical liquid.
"According to my speculation, if it is a three-party cooperation, Mr. Xue, you will definitely get 50% of the profit, and we can share 30%, while the other partner will invest in technology and share 20% of the profit."
Hearing Zhao Jianjun's words, Xue Chen thought quickly and felt that what he said was somewhat interesting. Obviously, if it was really distributed like this, it would mean that Huaxia Pharmaceutical Group gave up part of its profits to him. After all, he did the most work.
They put in the most effort, but only get 30% of the profit.
"Mr. Zhao, I am willing to agree with this proposal, but can it be passed on your side?" For such a large pharmaceutical group, not one person can have the final say.
Zhao Jianjun smiled heartily: "I can still guarantee this. What's more, this is not a loss-making business. Although the 30% profit is less than one-third, no matter how small the mosquito is, it is still meat, right? And there is no doubt that it is still meat.
, once it is produced in our country, it will definitely create more job opportunities and tax revenue, which I have also taken into consideration."
Of course, he has more than this in mind. Although there is still no trace of the actual development of the product, after this period of understanding and thinking, he has deeply realized the huge potential of this health care liquid.
This is an extremely important opportunity that cannot be missed no matter what. Since you don’t have the skills, you can only find another way to get involved. You must not become a bystander.
The two discussed some more details and basically finalized the proposal just now, involving Huaxia Pharmaceutical Group Corporation. As for which of the four pharmaceutical companies that have mastered the replication technology to cooperate with, further work is needed.
Negotiation and engagement.
And Zhao Jianjun also took over the matter and said that he could handle it. Xue Chen smiled lightly and said okay. He had nothing to worry about. Was he being plotted or dug into? In the final analysis
, only he has the rejuvenation solution, it is the real core, so there is no need to worry.
The next day, four international pharmaceutical companies learned about the agreement reached between Huaxia Pharmaceutical Group Corporation and Xue Chen, and also obtained specific information. The top management of the board of directors immediately held a meeting.
Of course, the four international pharmaceutical companies have expressed a certain degree of dissatisfaction and dissatisfaction. This was originally just a personal negotiation and cooperation with Xue Chen, but now such a powerful and well-backed colleague suddenly appeared, and they were all very unhappy.
And Zhao Jianjun also gave the four pharmaceutical companies a message: Don't ask them to spend money. As long as they provide replication technology and subsequent development and research, they can get 20% of the profits for free. This kind of good thing is hard to find even with a lantern. If you want to cooperate,
I quickly agreed, otherwise there would be no such temple after passing this village.
Zhao Jianjun is not afraid that these pharmaceutical companies will not agree, so he should continue to delay. Maybe one day their scientific researchers will also develop replication technology, and then the four international pharmaceutical companies will be able to kick them away. This is
The situation he most wanted to see.
It would be great if you agree. The factories, production lines and production personnel are all in China. Is it not easy to learn the technology? As long as you master the technology, you can still kick it away.
Although the top executives of the four international pharmaceutical companies are not angry, they are not overwhelmed by anger. They are also clearly aware that this matter has become a foregone conclusion and they have no ability to make changes. They cannot delay it any longer, otherwise they will be robbed.
The loss will be greater if you do it first.
Almost on the same day, four international pharmaceutical companies expressed their willingness to accept new cooperation methods and could use their technologies to cooperate.
After meeting the four international pharmaceutical companies who all hurriedly accepted it, Zhao Jianjun and the leaders of Huaxia Pharmaceutical Group couldn't help but sigh. This feeling of taking the initiative is really good. This kind of situation was really bad in the past.
This is rare. After all, even Takeda Pharmaceuticals, which is the weakest among the four pharmaceutical companies in terms of overall strength, is slightly stronger than Huaxia Pharmaceutical Group, not to mention Pfizer, Johnson & Johnson and Novartis. The specific drugs they produce are enough to make these drugs
Extremely proud.
The senior leaders within Huaxia Pharmaceutical Group Corporation held a meeting in a timely manner and discussed only one thing. All four pharmaceutical companies agreed, so which one should be chosen?
After some discussion, we basically reached a consensus that Takeda Pharmaceutical is a more suitable choice.
First of all, Takeda Pharmaceutical is the weakest. When it comes to cooperation, of course it is more comfortable to cooperate with people of similar strength.
Secondly, it involves historical issues. Many senior executives of Huaxia Medicine headed by Zhao Jianjun have the same idea in their hearts, which is to secretly learn the technology. When that day comes, there will inevitably be some shocks and public opinion issues.
They may not care about foreign opinions, but domestic public opinion must be taken seriously, and Takeda Pharmaceutical is a Japanese company, so when that day comes, it will be easy to guide public opinion, at least they will not be criticized domestically, maybe.
I will also give them 32 likes and give them a national hero banner.
At this time, the senior management of Takeda Pharmaceutical did not know this, otherwise they would have been furious and said that I should not say what I said in MMP.
Zhao Jianjun informed Xue Chen about the group's internal decisions and asked Xue Chen if he had any opinions.
Xue Chen said it didn't matter. He didn't have much connection with the four pharmaceutical companies. It didn't matter which one he chose. The technologies of the four pharmaceutical companies were all about the same, and no one was particularly outstanding or excellent.
When he was about to end the conversation, his mind suddenly moved and he mentioned one more thing to Zhao Jianjun, and Zhao Jianjun made a note of it in his mind.
After receiving the reply from Huaxia Pharmaceutical Group, the atmosphere inside Takeda Pharmaceutical was still very jubilant. Although it was a little worse than originally expected, it was not too bad. At least the research and development technology was not in vain, and it was better than the other three companies.
.
The content of the cooperation has basically been determined, without much change. Takeda Pharmaceutical is responsible for technology and subsequent continued research and development, and Huaxia Pharmaceutical Group is responsible for production and sales. Each party will receive 20% of the net profit and
Thirty, the final 50% of the profit belongs to Xue Chen.
However, in the end, Huaxia Medicine came up with the basis for cooperation, hoping that Kojima would give up his love and sell the pair of dragon-patterned jade stones he collected.
When Koshimada heard the news, he immediately guessed that it must be what Xue Chen wanted. He was reluctant in his heart, but in the end, after weighing it again and again, he gritted his teeth and took it out.
Xue Chen is not a completely unreasonable person. He paid 12 million U.S. dollars, which is 2 million U.S. dollars more than Kojima's purchase price, which is considered to be in line with the laws of the market.
In order to make up for Kojima, Takeda Pharmaceutical executives sent people to China to take charge of all matters related to the tripartite cooperation and serve as the top person in charge.
Kojimadaichi knew that the potential of the health care medicines to be co-produced would be disruptive, and his status and identity would also rise with the tide. Thinking of this, the depression of losing his treasures was alleviated a lot.
After confirming the cooperation agreement, Huaxia Pharmaceutical Group Corporation immediately started taking action, freeing up several large-scale production lines in Beijing and selecting thousands of outstanding production personnel. The scientific researchers of Takeda Pharmaceutical also arrived by plane.
to the capital.
Both parties in the tripartite cooperation were busy, but Xue Chen, who would take away half of the profits, was as leisurely as before, and finally got the pair of dragon-patterned jade that made Qu Liancheng's family go crazy!
The things were packed in a sophisticated silver-white suitcase. Xue Chen took it back home, placed it on the coffee table in the living room, and opened it carefully.
Jiang Huilan, who brought some slices of iced watermelon, stood aside and watched carefully. She didn't know what was in the box, but when she saw such a beautiful box and Xue Chen's movements were so cautious, she guessed that it must be something special.
's baby.
The box was opened, and inside was a soft yellow fabric spread among special molds. The molds below were like two lungs of the human body, with one on the left and one on the right recessed, and a semicircular piece was embedded in each of these two places.
jade!
"This is...Kunlun Jade?"
Xue Chen murmured when he saw two pieces of jade with a lot of history.
There is no doubt that the material of these two pieces of jade is Kunlun jade!
Kunlun jade is also called Qinghai jade today because its main production area is located near the Kunlun Mountains in Qinghai Province.
But now when Qinghai jade is mentioned, it will give people a feeling of low-end and inferior quality. Of course, there is a reason for this. The biggest reason is that a large number of counterfeit Hetian jade on the market are inferior Qinghai jade, so it gives people a feeling of low-end and inferior quality.
I feel that Qinghai jade is very low-end, but in fact it is not.
If we look at the true history, it is wrong to call Kunlun jade Qinghai jade, because the main mineral veins that produce Hetian jade are also part of the Kunlun Mountains. So tracing back to the source, whether Qinghai jade and Hetian jade belong to Kunlun jade, it is just
Qinghai jade is located to the east of Kunlun, and Hetian jade is located to the north of Kunlun.
But later Hetian jade was separated from Kunlun jade and became a separate category. As for why this happened, in Xue Chen’s opinion, the root cause is because of the power of capital, through publicity and hype, etc., so that Hetian jade
It is superior to many jade varieties and has a tendency to become the king of jade. (To be continued)